Percutaneous coronary intervention for major bifurcation lesions using the simple approach: risk of myocardial

Eram C Chaudhry1, Kimberly P Dauerman, Christopher L Sarnoski

  • 1Division of Cardiology, McClure 1, University of Vermont College of Medicine, 111 Colchester Avenue, Burlington, VT 05401, USA.

Insights

Simple stenting for bifurcation lesions has a significant rate of side branch compromise and periprocedural myocardial infarction (MI). Predictors include diabetes and lesion characteristics, highlighting risks in unselected patients.

Area of Science:

  • Interventional Cardiology
  • Vascular Medicine
  • Medical Device Technology

Background:

  • Percutaneous coronary intervention (PCI) for bifurcation lesions remains complex.
  • Simple stenting, focusing on the main vessel, is increasingly suggested as a preferred strategy.
  • Outcomes of this approach in a real-world setting require further investigation.

Purpose of the Study:

  • To assess the feasibility and clinical outcomes of provisional main vessel stenting in patients with major coronary artery bifurcation lesions.
  • To identify predictors of side branch (SB) compromise following this stenting strategy.

Main Methods:

  • A registry analysis of 1,600 consecutive patients undergoing PCI between August 2004 and 2005.
  • Identification of patients with major bifurcation lesions (>=70% stenosis in main vessel or side branch >=2mm).
  • Analysis of angiographic, clinical, and treatment factors associated with final SB compromise (>=70% stenosis or TIMI <3 flow).

Main Results:

  • 158 patients underwent provisional main vessel stenting.
  • Permanent SB compromise occurred in 16% of patients, linked to increased risk of periprocedural myocardial infarction (MI) and renal failure.
  • Independent predictors of SB compromise included lack of pre-PCI beta-blockers, diabetes mellitus, eccentric main vessel lesion, and small SB diameter.

Conclusions:

  • The "simple" provisional main vessel stenting approach for major bifurcation lesions is associated with a notable rate of significant periprocedural complications.
  • Side branch compromise is a critical endpoint that warrants careful consideration and risk factor management.
  • Further strategies may be needed to mitigate risks in unselected patient populations undergoing this technique.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...